The VGXI Team is attending #ISCTNA2023 next month in Houston! Click the link to meet Christy Franco, Ph.D. and Michelle Stretz, MSc at the event: hubs.ly/Q01_-Gzq0 #cellandgenetherapy #vgxi #CDMO #plasmid

VGXI's team of industry experts will be attending and invite you to schedule a meeting to discuss how VGXI's leading-edge capabilities can support your cell & gene therapy needs. Schedule a meeting on the PartneringOne app. #plasmid #HoustonTx #CGMesa23

Hello from Carlsbad, California! It's Day 1 at Alliance for Regenerative Medicine, Meeting on the Mesa 2023. The VGXI's team is ready to connect with experts and leaders in the cell and gene therapy sector. #CGMesa23 #plasmid

The burgeoning field of vaccine development is taking center stage this week at The World Vaccine Congress 2023! Join us in Barcelona as we meet with key partners and global industry leaders. #plasmid #WVCEU #VGXI #Barcelona #vaccine

Join us in the beautiful city of Barcelona for CPHI Worldwide! VGXI’s Chief Commercial Officer Jeff Whitmore will be present at the event and is excited for the chance to connect with like-minded thought leaders, trailblazers, and innovators on the future of pharma. #CPHIBCN

VGXI’s kicking off the New Year with bang! We’re attending J.P. Morgan's 41st annual Healthcare Conference to connect with global industry leaders, biopharmaceutical companies and innovative technology providers. We hope to see you there! #jpm2024 #JPMHealthcare #vgxi #plasmid

Greetings from San Fransico! It has been absolutely thrilling to hear about the positive market updates at #JPM2024! The future looks bright, and we couldn't be more proud of our incredible VGXI team. #jpm2024

Fresh off the heels of #JPM2024, VGXI is setting its sights on Miami, FL for Phacilitate’s Advanced Therapies Week, happening from Jan 16-19th. Be sure to stop by booth #615 to connect with us! hubs.ly/Q02gbKmx0 #atw2024 #AdvancedTherapiesWeek

Visit VGXI at booth #615 during Phaciliate's Advance Therapies Week to discover our leading-edge technologies and manufacturing capabilities. Don't miss the opportunity to learn more about VGXI's innovative solutions and stay ahead in the industry. #ATW2024 #plamsid #VGXI

Two milestone approvals for sickle cell disease gene therapies came at the end of 2023, bringing the FDA total for rare genetic diseases to 10. Take a look at the pipeline and more in @ Alliance for Regenerative Medicine's Sector Snapshot: bit.ly/3OAMHoI

Join us at Johnson & Johnson's groundbreaking gene therapy event tomorrow to hear about insights and industry best practices. Michelle Stretz, Sr. Manager of Business Development, is attending at the San Francisco Bay Campus. Schedule a meeting. bit.ly/49uJUFC

Today's conversations focused on innovating and unleashing the potential of early scientific discoveries within gene therapy. It's an exciting place to be for anyone passionate about driving forward medical advancements! #CDMO #pDNA #VGXI

The companies leveraging DNA vaccines are INOVIO Pharmaceuticals, Zydus Cadila, Ichor Medical Systems, Takis Biotech, Applied DNA Sciences, VGXI, Inc., Zydus, AnGes, GeneOne Life Science, Inc., etc. Zydus Lifesciences Ltd.

“There are over 6000 rare diseases, characterized by a broad diversity of disorders and symptoms that vary from disease to disease but also from patient to patient.” #VGXI #pDNA #GeneandCellTherapy #RAREDISEASEDAY

VGXI's Michelle Stretz, Senior Manager of Business Development is attending The DNA Process Development & Manufacturing Summit in Boston, MA. It's going to be an engaging event with Dee dives into process development, analytical assays, and regulatory compliance. #pDNA #VGXI

Breaking News: VGXI's New Website is Here! We're thrilled to announce that VGXI's new website is officially live! Our new and improved design makes it easier than ever to explore our plasmid DNA products and customizable services bit.ly/4afIPC1

Join VGXI at the 7th Annual Gene Therapy for Rare Disorders Summit to explore how our technology innovations and DNA manufacturing solutions support the acceleration of safe and effective gene therapies. bit.ly/43qnMui #plasmidDNA #genetherapy #Raredisorder

VGXI is proud to announce the appointment of Stephanie Burke as its new Chief Accounting Officer! Click here to learn more: prn.to/43AFETj #vgxi #plasmidDNA‍ #pdna #greatplacetowork #pressrelease

Just Released: VGXI’s Pre-Clinical Plasmid Production Flyer! Click the link below to access a comprehensive resource of pre-clinical plasmid DNA manufacturing solutions. Access here: bit.ly/4dVAIgz

AAV-based therapies are redefining medicine - are your plasmids ready? At VGXI, we power gene therapy with optimized plasmid design, expert AAV support, and GMP manufacturing built for success. Learn more: vgxii.com/applications/g… #AAV #PlasmidDNA #Biotech #VGXI